SS-31 25 mg

Peptide Sciences USA
  • Active Substance: SS-31 Mitochondria-Targeting Peptide (Elamipretide)
  • Concentration: 25 mg per vial
  • Pack Size: Single vial (lyophilized powder)
  • Manufacturer: Peptide Sciences USA
  • Brand Name: Elamipretide
  • Molecular Formula: C32H49N9O5
  • Molecular Weight: 639.8 g/mol
  • Sequence: D-Arg-2,6-dimethylTyr-Lys-Phe-NH2
  • Synonyms: Elamipretide, Bendavia, MTP-131
Manufacturer Peptide Sciences USA
Brand Forzinity
Substance SS-31 Mitochondria-Targeting Peptide
Concentration 25 mg
Pack Size vial
Out of Stock

SS-31 25 mg – Tide of Cellular Renewal

Launch Your Mitochondrial Research

Envision a lab where cells thrive, energy surges, and aging slows. SS-31 25 mg from Peptide Sciences USA sparks breakthroughs. This mitochondria-targeting peptide optimizes ATP production and reduces oxidative stress, driving transformative studies in energy, neuroprotection, and anti-aging. It's your tide for pioneering cellular health research, crafted for visionary researchers like you.

The Science Behind Cellular Renewal

SS-31 (Elamipretide, sequence: D-Arg-2,6-dimethylTyr-Lys-Phe-NH2) is a synthetic tetrapeptide that targets the inner mitochondrial membrane, binding to cardiolipin to stabilize cristae structure. It enhances ATP production, reduces reactive oxygen species (ROS), and prevents mitochondrial dysfunction. In mouse studies, SS-31 (3 mg/kg/day, 8 weeks) improved exercise endurance by 70% and reversed age-related mitochondrial decline.

It shows promise in mitochondrial myopathies, heart failure, neurodegenerative diseases (e.g., Alzheimer's, Parkinson's), kidney disease, and age-related macular degeneration. The 25 mg vial is ideal for injectable research into cellular energy and age-related conditions.

Why SS-31 25 mg Fuels Your Studies

SS-31 isn't just a peptide—it's a tide that redefines cellular health research. Here's what makes it shine:

  • Energy Optimization: Boosts ATP production, enhancing cellular energy.
  • Anti-Aging Support: Reduces oxidative stress linked to aging.
  • Neuroprotection: Protects neurons in Alzheimer's and Parkinson's models.
  • Heart Health: Improves cardiac function in heart failure models.
  • Top Quality: Crafted by Peptide Sciences USA with 99% purity.

With SS-31 25 mg, you're not just studying—you're sparking cellular health breakthroughs.

Product Specifications

Peptide Sciences USA's SS-31 25 mg is your key to cutting-edge mitochondrial research. Here's the breakdown:

  • Composition: Contains 25 mg SS-31 (C32H49N9O5, 639.8 g/mol).
  • Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous injection.
  • Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by HPLC and Mass Spectrometry.
  • Usage Guidelines: Reconstitute with 1 mL bacteriostatic water (25 mg/mL). Inject 4–10 mg subcutaneously daily for 4–12 weeks. Dosing is experimental for research only. Use under professional supervision.
  • Storage: Store lyophilized powder at -20°C for long-term stability or 4°C for short-term use (up to 6 weeks). After reconstitution, refrigerate at 2–8°C and use within 4 weeks.
  • Safety: Common side effects include mild injection site reactions, headaches, or dizziness; limited human data requires oversight.

This peptide is for research purposes only, driving discoveries in mitochondrial and cellular health.

Frequently Asked Questions

What is the use of SS-31 peptide?

SS-31 is studied for mitochondrial myopathies, heart failure, neurodegenerative diseases, kidney disease, and eye health.

What are the side effects of SS-31 peptide?

Mild side effects include injection site reactions, headaches, or dizziness; limited human data requires oversight.

Does SS-31 give you energy?

SS-31 boosts ATP production, improving cellular energy and endurance by 70% in mouse studies.

Can SS-31 reverse aging?

SS-31 may slow aging by reducing oxidative stress but cannot reverse it.

How is SS-31 25 mg administered in research?

Reconstitute with 1 mL bacteriostatic water (25 mg/mL). Inject 4–10 mg daily subcutaneously for 4–12 weeks.